BeneditoArrudaCarneiro FilhoMD

PubMed

• Harnessing artificial intelligence for prostate cancer management.
  Lingxuan Zhu, Jiahua Pan, Weiming Mou, Longxin Deng, Yinjie Zhu, Yanqing Wang, Gyan Pareek, Elias Hyams, Benedito A Carneiro, Matthew J Hadfield, Wafik S El-Deiry, Tao...> ;Cell Reports. Medicine. 2024 Apr 16
• Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management.
  Yibo Shi, Hanzhang Wang, Borivoj Golijanin, Ali Amin, Joanne Lee, Mark Sikov, Elias Hyams, Gyan Pareek, Benedito A Carneiro, Anthony E Mega, Galina G Lagos, Lisha Wang...> ;Urologic Oncology. 2024 May 1
• 1 citations
  Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors.
  Sandip P Patel, Teresa Alonso-Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan E Standifer, Doug C Palmer, Lin-Yang Cheng, Panagiotis Kourtesis, Maria L Asc...> ;Journal for Immunotherapy of Cancer. 2024 Feb 2
• Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies.
  Davis, E., Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, Anwaar Saeed, Howard Safran, Wen Wee Ma, Andrew L Coveler, Steven Powell, Bruno Bastos, Eli...> ;Clinical Cancer Research. 2024 Feb 1
• 1 citations
  Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
  Wei, S., Krause, H., Geynisman, D., Elliott, A., Kutikov, A., Uzzo, R., Pei, J., Barata, P., Carneiro, B., Heath, E., Ryan, C., Farrell, A., Nabhan, C., Ali-Fehmi, R.,...> ;Modern Pathology. 2024 Feb 1
• Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT).
  Purbhoo, M., Grossman, J., Buell, J., Hadfield, M., Safran, H., Carneiro, B.> ;Oncogene. 2024 Mar 1
• 1 citations
  Predictive and prognostic biomarkers in urological tumours.
  Cimadamore, A., Franzese, C., Di Loreto, C., Blanca, A., Lopez-Beltran, A., Crestani, A., Giannarini, G., Tan, P., Montironi, R., Carneiro, B., El-Deiry, W., Cheng, L.> ;Pathology. 2024 Mar 1
• 1 citations
  Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib.
  Ezra Rosen, Timothy A Yap, Elizabeth K Lee, Martin Højgaard, Niharika B Mettu, Stephanie Lheureux, Benedito A Carneiro, Ruth Plummer, Adrian J Fretland, Danielle Ulane...> ;Clinical Cancer Research. 2024 Feb 16
• 1 citations
  Opposing Roles ofMutations in Human Prostate and Endometrial Cancers.
  Ludimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R Ribeiro, Benedito A Carneiro, Don S Dizon, Kartik Angara, Tyler Mattox, Sharon Wu, Joanne Xiu, Phillip Walker, M...> ;JCO Precision Oncology. 2023 Sep 1
• GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.
  Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Fr...> ;International Journal of Molecular Sciences. 2023 Jun 29
• 11 citations
  Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
  Timothy A Yap, Elisa Fontana, Elizabeth K Lee, David R Spigel, Martin Højgaard, Stephanie Lheureux, Niharika B Mettu, Benedito A Carneiro, Louise Carter, Ruth Plummer,...> ;Nature Medicine. 2023 Jun 1
• 5 citations
  Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
  Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-C...> ;Eclinicalmedicine. 2023 Jun 1
• Addendum:: a novel gene fusion in hepatic angiosarcoma.
  Eric I Marks, Sahithi Pamarthy, Don Dizon, Ari Birnbaum, Evgeny Yakirevich, Howard Safran, Benedito A Carneiro> ;Oncotarget. 2023 May 26
• 1 citations
  Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes.
  Justin Hwang, Xiaolei Shi, Andrew Elliott, Taylor E Arnoff, Julie McGrath, Joanne Xiu, Phillip Walker, Hannah E Bergom, Abderrahman Day, Shihab Ahmed, Sydney Tape, All...> ;Clinical Cancer Research. 2023 Jul 14
• 3 citations
  Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
  Sean M Hacking, Dean Pavlick, Yihong Wang, Benedito A Carneiro, Matthew Mullally, Shaolei Lu, Mariana Canepa, Gennady Bratslavsky, Joseph Jacob, Andrea Necchi, Philipp...> ;The Oncologist. 2023 Jul 5
• 7 citations
  Therapeutic targeting of TRAIL death receptors.
  Francesca Di Cristofano, Andrew George, Vida Tajiknia, Maryam Ghandali, Laura Wu, Yiqun Zhang, Praveen Srinivasan, Jillian Strandberg, Marina Hahn, Ashley Sanchez Sevi...> ;Biochemical Society Transactions. 2023 Feb 27
• 1 citations
  GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer.
  Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A Borden, Fr...> ;Biorxiv. 2023 Feb 7
• 4 citations
  Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
  Stephen K Tahir, Emiliano Calvo, Benedito A Carneiro, Junichiro Yuda, Aditya Shreenivas, Mojca Jongen-Lavrencic, Eelke Gort, Kenichi Ishizawa, Daniel Morillo, Carla Bi...> ;Blood. 2023 Apr 27
• Expression of tumoral GSK3-β, PD-L1, and CD8 cell density in urothelial carcinomas, association with tumor grade and overall survival.
  Aline Kimberly Almeida Rodrigues, Paulo Goberlanio Silva, Cleto Nogueira, Samuel S Ferreira, Juliana Cordeiro, Fabio Tavora, Carneiro, B.> ;American Journal of Clinical and Experimental Immunology. 2023 Jan 1
• 3 citations
  Clinical features of patients with-deleted bladder cancer.
  Andre L De Souza, Anthony E Mega, John Douglass, Adam J Olszewski, Ece D Gamsiz Uzun, Alper Uzun, Charissa Chou, Fenghai Duan, Jinyu Wang, Amin Ali, Dragan J Golijanin...> ;American Journal of Cancer Research. 2023 Jan 1
• 2 citations
  Synergistic activity of ABT-263 and ONC201/TIC10 against solid tumor cell lines is associated with suppression of anti-apoptotic Mcl-1, BAG3, pAkt, and upregulation of...
  Francesca R Di Cristofano, Mara W Fong, Kelsey E Huntington, Benedito A Carneiro, Lanlan Zhou, Wafik S El-Deiry> ;American Journal of Cancer Research. 2023 Jan 1
• 4 citations
  Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma.
  Andrew Hsu, Kelsey E Huntington, Andre De Souza, Lanlan Zhou, Adam J Olszewski, Nirav P Makwana, Diana O Treaba, Ludimila Cavalcante, Francis J Giles, Howard Safran, W...> ;Cancer Biology & Therapy. 2022 Dec 31
• 3 citations
  Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced gliob...
  Benedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, Andrew B Lassman, Saiama N Waqar, Young Kwang Chae, Jyoti D Patel, Einat Shacham-Shmueli, Karen Kelly, ...> ;Neuro-Oncology Advances. 2022 Dec 21
• 6 citations
  Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents.
  Sourat Darabi, David R Braxton, Joanne Xiu, Benedito A Carneiro, Jeff Swensen, Emmanuel S Antonarakis, Stephen V Liu, Rana R McKay, David Spetzler, Wafik S El-Deiry, M...> ;Medicina. 2022 Dec 10
• 7 citations
  Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study.
  Patricia LoRusso, Mark J Ratain, Toshihiko Doi, Drew W Rasco, Maja J A de Jonge, Victor Moreno, Benedito A Carneiro, Lot A Devriese, Adam Petrich, Dimple Modi, Susan M...> ;Investigational New Drugs. 2022 Aug 1
• Join now to see all